Allergen reference doses for precautionary labeling (VITAL 2.0): Clinical implications

Katrina J. Allen, Benjamin C. Remington, Joseph L Baumert, Rene W.R. Crevel, Geert F. Houben, Simon Brooke-Taylor, Astrid G. Kruizinga, Stephen L Taylor

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Background There has been a dramatic proliferation of precautionary labeling by manufacturers to mitigate the perceived risk from low-level contamination from allergens in food. This has resulted in a significant reduction in choice of potentially safe foods for allergic consumers. Objectives We aimed to establish reference doses for 11 commonly allergenic foods to guide a rational approach by manufacturers based on all publically available valid oral food challenge data. Methods Reference doses were developed from statistical dose-distribution modeling of individual thresholds of patients in a dataset of more than 55 studies of clinical oral food challenges. Sufficient valid data were available for peanut, milk, egg, and hazelnut to allow assessment of the representativeness of the data used. Results The data were not significantly affected by the heterogeneity of the study methodology, including little effect of age on results for those foods for which sufficient numbers of adult challenge data were available (peanut and hazelnut). Thus by combining data from all studies, the eliciting dose for an allergic reaction in 1% of the population estimated for the following were 0.2 mg of protein for peanut, 0.1 mg for cow's milk, 0.03 mg for egg, and 0.1 mg for hazelnut. Conclusions These reference doses will form the basis of the revised Voluntary Incidental Trace Allergen Labeling (VITAL) 2.0 thresholds now recommended in Australia. These new levels will enable manufacturers to apply credible precautionary labeling and provide increased consumer confidence in their validity and reliability, as well as improving consumer safety.

Original languageEnglish (US)
Pages (from-to)156-164
Number of pages9
JournalJournal of Allergy and Clinical Immunology
Volume133
Issue number1
DOIs
StatePublished - Jan 1 2014

Fingerprint

Allergens
Corylus
Food
Ovum
Milk
Statistical Distributions
Reproducibility of Results
Hypersensitivity
Safety
Population
Arachis
Proteins

Keywords

  • Food allergy
  • allergen thresholds
  • cow's milk
  • egg
  • hazelnut
  • peanut
  • precautionary labeling
  • soy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Allergen reference doses for precautionary labeling (VITAL 2.0) : Clinical implications. / Allen, Katrina J.; Remington, Benjamin C.; Baumert, Joseph L; Crevel, Rene W.R.; Houben, Geert F.; Brooke-Taylor, Simon; Kruizinga, Astrid G.; Taylor, Stephen L.

In: Journal of Allergy and Clinical Immunology, Vol. 133, No. 1, 01.01.2014, p. 156-164.

Research output: Contribution to journalArticle

Allen, Katrina J. ; Remington, Benjamin C. ; Baumert, Joseph L ; Crevel, Rene W.R. ; Houben, Geert F. ; Brooke-Taylor, Simon ; Kruizinga, Astrid G. ; Taylor, Stephen L. / Allergen reference doses for precautionary labeling (VITAL 2.0) : Clinical implications. In: Journal of Allergy and Clinical Immunology. 2014 ; Vol. 133, No. 1. pp. 156-164.
@article{8198996937e44883851dba7f0945ccb0,
title = "Allergen reference doses for precautionary labeling (VITAL 2.0): Clinical implications",
abstract = "Background There has been a dramatic proliferation of precautionary labeling by manufacturers to mitigate the perceived risk from low-level contamination from allergens in food. This has resulted in a significant reduction in choice of potentially safe foods for allergic consumers. Objectives We aimed to establish reference doses for 11 commonly allergenic foods to guide a rational approach by manufacturers based on all publically available valid oral food challenge data. Methods Reference doses were developed from statistical dose-distribution modeling of individual thresholds of patients in a dataset of more than 55 studies of clinical oral food challenges. Sufficient valid data were available for peanut, milk, egg, and hazelnut to allow assessment of the representativeness of the data used. Results The data were not significantly affected by the heterogeneity of the study methodology, including little effect of age on results for those foods for which sufficient numbers of adult challenge data were available (peanut and hazelnut). Thus by combining data from all studies, the eliciting dose for an allergic reaction in 1{\%} of the population estimated for the following were 0.2 mg of protein for peanut, 0.1 mg for cow's milk, 0.03 mg for egg, and 0.1 mg for hazelnut. Conclusions These reference doses will form the basis of the revised Voluntary Incidental Trace Allergen Labeling (VITAL) 2.0 thresholds now recommended in Australia. These new levels will enable manufacturers to apply credible precautionary labeling and provide increased consumer confidence in their validity and reliability, as well as improving consumer safety.",
keywords = "Food allergy, allergen thresholds, cow's milk, egg, hazelnut, peanut, precautionary labeling, soy",
author = "Allen, {Katrina J.} and Remington, {Benjamin C.} and Baumert, {Joseph L} and Crevel, {Rene W.R.} and Houben, {Geert F.} and Simon Brooke-Taylor and Kruizinga, {Astrid G.} and Taylor, {Stephen L}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.jaci.2013.06.042",
language = "English (US)",
volume = "133",
pages = "156--164",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Allergen reference doses for precautionary labeling (VITAL 2.0)

T2 - Clinical implications

AU - Allen, Katrina J.

AU - Remington, Benjamin C.

AU - Baumert, Joseph L

AU - Crevel, Rene W.R.

AU - Houben, Geert F.

AU - Brooke-Taylor, Simon

AU - Kruizinga, Astrid G.

AU - Taylor, Stephen L

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background There has been a dramatic proliferation of precautionary labeling by manufacturers to mitigate the perceived risk from low-level contamination from allergens in food. This has resulted in a significant reduction in choice of potentially safe foods for allergic consumers. Objectives We aimed to establish reference doses for 11 commonly allergenic foods to guide a rational approach by manufacturers based on all publically available valid oral food challenge data. Methods Reference doses were developed from statistical dose-distribution modeling of individual thresholds of patients in a dataset of more than 55 studies of clinical oral food challenges. Sufficient valid data were available for peanut, milk, egg, and hazelnut to allow assessment of the representativeness of the data used. Results The data were not significantly affected by the heterogeneity of the study methodology, including little effect of age on results for those foods for which sufficient numbers of adult challenge data were available (peanut and hazelnut). Thus by combining data from all studies, the eliciting dose for an allergic reaction in 1% of the population estimated for the following were 0.2 mg of protein for peanut, 0.1 mg for cow's milk, 0.03 mg for egg, and 0.1 mg for hazelnut. Conclusions These reference doses will form the basis of the revised Voluntary Incidental Trace Allergen Labeling (VITAL) 2.0 thresholds now recommended in Australia. These new levels will enable manufacturers to apply credible precautionary labeling and provide increased consumer confidence in their validity and reliability, as well as improving consumer safety.

AB - Background There has been a dramatic proliferation of precautionary labeling by manufacturers to mitigate the perceived risk from low-level contamination from allergens in food. This has resulted in a significant reduction in choice of potentially safe foods for allergic consumers. Objectives We aimed to establish reference doses for 11 commonly allergenic foods to guide a rational approach by manufacturers based on all publically available valid oral food challenge data. Methods Reference doses were developed from statistical dose-distribution modeling of individual thresholds of patients in a dataset of more than 55 studies of clinical oral food challenges. Sufficient valid data were available for peanut, milk, egg, and hazelnut to allow assessment of the representativeness of the data used. Results The data were not significantly affected by the heterogeneity of the study methodology, including little effect of age on results for those foods for which sufficient numbers of adult challenge data were available (peanut and hazelnut). Thus by combining data from all studies, the eliciting dose for an allergic reaction in 1% of the population estimated for the following were 0.2 mg of protein for peanut, 0.1 mg for cow's milk, 0.03 mg for egg, and 0.1 mg for hazelnut. Conclusions These reference doses will form the basis of the revised Voluntary Incidental Trace Allergen Labeling (VITAL) 2.0 thresholds now recommended in Australia. These new levels will enable manufacturers to apply credible precautionary labeling and provide increased consumer confidence in their validity and reliability, as well as improving consumer safety.

KW - Food allergy

KW - allergen thresholds

KW - cow's milk

KW - egg

KW - hazelnut

KW - peanut

KW - precautionary labeling

KW - soy

UR - http://www.scopus.com/inward/record.url?scp=84891746748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891746748&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2013.06.042

DO - 10.1016/j.jaci.2013.06.042

M3 - Article

C2 - 23987796

AN - SCOPUS:84891746748

VL - 133

SP - 156

EP - 164

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 1

ER -